07:51 AM EDT, 09/18/2025 (MT Newswires) -- Aurora Cannabis ( ACB ) said Thursday that it plans to invest over five years in operational upgrades at its EU-GMP manufacturing facility in Leuna, Germany.

Financial details of the investment were not disclosed.

The company said these upgrades aim to increase flower growth capacity, product quality and drive cost efficiency.

The plant contributes to the supply of locally grown medical cannabis to Germany's expanding patient base, Aurora said.

Shares of the company were up more than 1% in recent Thursday premarket activity.